Income Statement Protalix BioTherapeutics, Inc.

Stocks

PLX

US74365A3095

Pharmaceuticals

Market Closed - NYSE 16:00:00 2026-09-18 EDT			5-day change	1st Jan Change
2.690 ^USD	-0.37%		+1.89%	+49.44%

09-16	Protalix BioTherapeutics, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-16-2026 01:05 PM
08-12	Protalix BioTherapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026

63e8dff6.B66BQbvy0-ZT1x2FvjHpfvtW-R9ttVo00QfvvbTfZj0.RvjyM8LHoaUatXDRi0aESKMBoC0HhwtMs0iJx9_oPH83_eYN04axnxLvKQ

Published financial data: PROTALIX BIOTHERAPEUTICS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	38.35M	47.64M	65.49M	53.4M	52.74M
Total Revenues	38.35M	47.64M	65.49M	53.4M	52.74M
Cost of Goods Sold, Total	16.35M	19.59M	22.98M	36.7M	45.88M
Gross Profit	22M	28.05M	42.51M	16.7M	6.86M
Selling General & Admin Expenses, Total	12.73M	11.71M	14.96M	12.19M	11.68M
R&D Expenses	29.73M	29.35M	17.09M	589K	680K
Other Operating Expenses, Total	42.46M	41.06M	32.05M	12.78M	12.36M
Operating Income	-20.46M	-13.01M	10.46M	3.92M	-5.5M
Interest Expense, Total	-6.29M	-2.53M	-3.18M	-1.06M	-1.19M
Interest And Investment Income	401K	1.15M	1.29M	1.3M	1.08M
Net Interest Expenses	-5.89M	-1.38M	-1.89M	237K	-108K
Other Non Operating Income (Expenses)	-396K	-	-	-	-
EBT, Excl. Unusual Items	-26.75M	-14.4M	8.57M	4.15M	-5.61M
Other Unusual Items	-831K	-	-	-	-
EBT, Incl. Unusual Items	-27.58M	-14.4M	8.57M	4.15M	-5.61M
Income Tax Expense	-	530K	254K	1.22M	996K
Earnings From Continuing Operations	-27.58M	-14.93M	8.31M	2.93M	-6.6M
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	-27.58M	-14.93M	8.31M	2.93M	-6.6M
Net Income - (IS)	-27.58M	-14.93M	8.31M	2.93M	-6.6M
Net Income to Common Incl Extra Items	-27.58M	-14.93M	8.31M	2.93M	-6.6M
Net Income to Common Excl. Extra Items	-27.58M	-14.93M	8.31M	2.93M	-6.6M
Per Share Items
Net EPS - Basic	-0.62	-0.31	0.12	0.04	-0.08
Basic EPS - Continuing Operations	-0.62	-0.31	0.12	0.04	-0.08
Basic Weighted Average Shares Outstanding	44.14M	48.47M	67.51M	72.53M	78.55M
Net EPS - Diluted	-0.62	-0.31	0.09	0.04	-0.08
Diluted EPS - Continuing Operations	-0.62	-0.31	0.09	0.04	-0.08
Diluted Weighted Average Shares Outstanding	44.14M	48.47M	82.42M	81.06M	78.55M
Normalized Basic EPS	-0.38	-0.19	0.08	0.04	-0.04
Normalized Diluted EPS	-0.38	-0.19	0.06	0.03	-0.04
Supplemental Items
EBITDA	-19.34M	-11.93M	11.65M	5.22M	-4.04M
EBITA	-20.46M	-13.01M	10.46M	3.92M	-5.5M
EBIT	-20.46M	-13.01M	10.46M	3.92M	-5.5M
EBITDAR	-17.71M	-10.53M	13.12M	6.86M	-2.22M
Total Revenues (As Reported)	38.35M	47.64M	65.49M	53.4M	52.74M
Effective Tax Rate - (Ratio)	-	-3.68	2.97	29.42	-17.76
Total Current Taxes	-	-	3.35M	986K	656K
Total Deferred Taxes	-	-	-3.09M	236K	340K
Normalized Net Income	-16.72M	-9M	5.35M	2.6M	-3.5M
Interest on Long-Term Debt	6.69M	2.53M	3.18M	1.06M	1.19M
Non-Cash Pension Expense	133K	145K	3K	-39K	22K
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	29.73M	29.35M	17.09M	12.97M	19.57M
Net Rental Expense, Total	1.63M	1.4M	1.47M	1.64M	1.82M
Imputed Operating Lease Interest Expense	1.68M	845K	1.25M	876K	2.5M
Imputed Operating Lease Depreciation	-47.25K	553K	218K	763K	-683K
Stock-Based Comp., COGS (Total)	269K	135K	596K	631K	431K
Stock-Based Comp., R&D Exp. (Total)	648K	518K	777K	589K	680K
Stock-Based Comp., SG&A Exp. (Total)	1.46M	1.43M	2.08M	2.03M	1.19M
Total Stock-Based Compensation	2.38M	2.08M	3.45M	3.25M	2.3M

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	38.98M	17.11M	23.63M	19.76M	14.68M
Short Term Investments	-	5.07M	20.93M	15.07M	15.59M
Total Cash And Short Term Investments	38.98M	22.18M	44.56M	34.83M	30.27M
Accounts Receivable, Total	3.44M	4.59M	5.27M	2.91M	8.84M
Other Receivables	311K	364K	482K	486K	634K
Total Receivables	3.75M	4.95M	5.75M	3.4M	9.47M
Inventory	17.95M	16.8M	19.04M	21.24M	25.73M
Prepaid Expenses	905K	774K	444K	500K	394K
Other Current Assets, Total	69K	172K	129K	110K	803K
Total Current Assets	61.67M	44.88M	69.93M	60.08M	66.67M
Gross Property Plant And Equipment	42.67M	43.33M	45.57M	45.76M	49.62M
Accumulated Depreciation	-32.75M	-33.69M	-34.69M	-35.74M	-37.05M
Net Property Plant And Equipment	9.92M	9.64M	10.88M	10.02M	12.58M
Deferred Tax Assets Long-Term	-	-	3.09M	2.86M	2.52M
Other Long-Term Assets, Total	2.08M	1.27M	528K	462K	578K
Total Assets	73.66M	55.79M	84.43M	73.42M	82.35M
Liabilities
Accounts Payable, Total	6.99M	5.86M	4.32M	4.53M	5.26M
Accrued Expenses, Total	16.34M	12.13M	13.2M	13.8M	14.53M
Current Portion of Long-Term Debt	-	-	20.25M	-	-
Current Portion of Leases	1.21M	1.12M	1.41M	1.5M	1.38M
Current Income Taxes Payable	-	-	2.88M	3.48M	2.95M
Unearned Revenue Current, Total	8.55M	13.18M	-	-	-
Other Current Liabilities	95K	143K	3.48M	2.31M	2.4M
Total Current Liabilities	33.18M	32.43M	45.53M	25.62M	26.52M
Long-Term Debt	27.89M	28.19M	-	-	-
Long-Term Leases	4.38M	4.17M	4.62M	4.03M	6.94M
Unearned Revenue Non Current	11.79M	-	-	-	-
Pension & Other Post Retirement Benefits	2.47M	1.64M	714K	559K	661K
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	79.7M	66.43M	50.86M	30.21M	34.12M
Common Stock, Total	46K	54K	73K	76K	80K
Additional Paid In Capital	369M	379M	415M	422M	433M
Retained Earnings	-375M	-390M	-382M	-378M	-385M
Total Common Equity	-6.04M	-10.64M	33.57M	43.21M	48.23M
Total Equity	-6.04M	-10.64M	33.57M	43.21M	48.23M
Total Liabilities And Equity	73.66M	55.79M	84.43M	73.42M	82.35M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	46.32M	57.35M	73.05M	78.03M	80.57M
ECS Total Common Shares Outstanding	45.56M	53.79M	72.95M	75.85M	80.43M
Book Value / Share	-0.13	-0.2	0.46	0.57	0.6
Tangible Book Value	-6.04M	-10.64M	33.57M	43.21M	48.23M
Tangible Book Value Per Share	-0.13	-0.2	0.46	0.57	0.6
Total Debt	33.47M	33.47M	26.28M	5.53M	8.32M
Net Debt	-5.52M	11.29M	-18.28M	-29.3M	-21.95M
Debt Equivalent of Unfunded Proj. Benefit Obligation	395K	375K	186K	97K	83K
Debt Equivalent Oper. Leases	13.06M	11.18M	11.77M	13.11M	14.52M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	3.17M	3.51M	4.18M	4.55M	5.98M
Inventories - Work In Process, Total	3.26M	2.68M	9.06M	11.24M	9.38M
Inventories - Finished Goods, Total	11.53M	10.62M	5.81M	5.45M	10.37M
Machinery, Total	20.96M	21.32M	22.02M	22.42M	23.86M
Full Time Employees	202	193	208	213	226
Part Time Employees	4	4	-	-	-

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	-27.58M	-14.93M	8.31M	2.93M	-6.6M
Depreciation & Amortization - CF	1.12M	1.09M	1.19M	1.3M	1.46M
Depreciation & Amortization, Total	1.12M	1.09M	1.19M	1.3M	1.46M
Amortization of Deferred Charges, Total - (CF)	2.67M	300K	267K	-	-
(Gain) Loss From Sale Of Asset	-51K	-	9K	-3K	-
Stock-Based Compensation (CF)	2.38M	2.08M	3.45M	3.25M	2.3M
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	1.28M	-1.53M	-4.01M	377K	948K
Change In Accounts Receivable	-1.03M	-1.19M	-428K	2.32M	-5.89M
Change In Inventories	-4.87M	1.15M	-2.24M	-2.2M	-4.49M
Change In Accounts Payable	2.38M	-4.8M	5.3M	696K	292K
Change in Unearned Revenues	13.23M	-7.16M	-13.18M	-	-
Change in Other Net Operating Assets	190K	-5K	13K	-4K	-15K
Cash from Operations	-10.28M	-25M	-1.32M	8.67M	-11.99M
Capital Expenditure	-1.46M	-628K	-1.15M	-1.28M	-1.64M
Sale of Property, Plant, and Equipment	53K	-	-	3K	-
Investment in Marketable and Equity Securities, Total	20M	-5M	-15.42M	5.42M	0
Other Investing Activities, Total	327K	593K	-142K	80K	-728K
Cash from Investing	18.92M	-5.04M	-16.71M	4.22M	-2.37M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Long-Term Debt Repaid, Total	-34.12M	-	-	-20.42M	-
Total Debt Repaid	-34.12M	-	-	-20.42M	-
Issuance of Common Stock	46.2M	8.24M	24.67M	3.63M	9.33M
Cash from Financing	12.08M	8.24M	24.67M	-16.79M	9.33M
Foreign Exchange Rate Adjustments	6K	-77K	-114K	25K	-47K
Net Change in Cash	20.72M	-21.87M	6.52M	-3.87M	-5.08M
Supplemental Items
Cash Interest Paid	3.41M	2.2M	2.74M	1.53M	-
Cash Income Tax Paid (Refund)	-	-	-	385K	1.18M
Levered Free Cash Flow	-12.09M	-7.55M	-1.81M	5.43M	-12.2M
Unlevered Free Cash Flow	-10.83M	-6.27M	-85.5K	6.1M	-11.45M
Change In Net Working Capital	75K	677K	10.11M	-375K	10.14M
Net Debt Issued / Repaid	-34.12M	-	-	-20.42M	-

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	-18.06	-12.57	9.32	3.1	-4.41
Return on Total Capital	-39.47	-32.36	15.81	4.51	-6.53
Return On Equity %	166.79	179.02	72.5	7.64	-14.44
Return on Common Equity	166.79	179.02	72.5	7.64	-14.44
Margin Analysis
Gross Profit Margin %	57.37	58.87	64.91	31.27	13.01
SG&A Margin	33.19	24.58	22.84	22.83	22.15
EBITDA Margin %	-50.44	-25.04	17.79	9.78	-7.65
EBITA Margin %	-53.36	-27.32	15.97	7.34	-10.43
EBIT Margin %	-53.36	-27.32	15.97	7.34	-10.43
Income From Continuing Operations Margin %	-71.92	-31.33	12.69	5.49	-12.52
Net Income Margin %	-71.92	-31.33	12.69	5.49	-12.52
Net Avail. For Common Margin %	-71.92	-31.33	12.69	5.49	-12.52
Normalized Net Income Margin	-43.6	-18.89	8.17	4.86	-6.65
Levered Free Cash Flow Margin	-31.53	-15.85	-2.76	10.18	-23.12
Unlevered Free Cash Flow Margin	-28.24	-13.16	-0.13	11.42	-21.71
Asset Turnover
Asset Turnover	0.54	0.74	0.93	0.68	0.68
Fixed Assets Turnover	3.77	4.87	6.38	5.11	4.67
Receivables Turnover (Average Receivables)	14.09	11.87	13.29	13.05	8.98
Inventory Turnover (Average Inventory)	1.05	1.13	1.28	1.82	1.95
Short Term Liquidity
Current Ratio	1.86	1.38	1.54	2.34	2.51
Quick Ratio	1.29	0.84	1.11	1.49	1.5
Operating Cash Flow to Current Liabilities	-0.31	-0.77	-0.03	0.34	-0.45
Days Sales Outstanding (Average Receivables)	25.9	30.75	27.47	28.04	40.65
Days Outstanding Inventory (Average Inventory)	346.45	323.77	284.68	200.89	186.84
Average Days Payable Outstanding	122.18	127.14	73.67	41.65	35.48
Cash Conversion Cycle (Average Days)	250.16	227.38	238.47	187.28	192.01
Long Term Solvency
Total Debt/Equity	-554.51	-314.61	78.29	12.79	17.25
Total Debt / Total Capital	122	146.6	43.91	11.34	14.71
LT Debt/Equity	-534.51	-304.1	13.77	9.32	14.38
Long-Term Debt / Total Capital	117.6	141.7	7.72	8.26	12.27
Total Liabilities / Total Assets	108.19	119.07	60.24	41.14	41.43
EBIT / Interest Expense	-3.25	-5.15	3.29	3.69	-4.62
EBITDA / Interest Expense	-2.81	-4.16	4.13	6.46	-1.86
(EBITDA - Capex) / Interest Expense	-3.05	-4.41	3.77	5.25	-3.24
Total Debt / EBITDA	-1.89	-3.18	2	0.81	-3.75
Net Debt / EBITDA	0.31	-1.07	-1.39	-4.27	9.89
Total Debt / (EBITDA - Capex)	-1.75	-3	2.2	0.99	-2.16
Net Debt / (EBITDA - Capex)	0.29	-1.01	-1.53	-5.25	5.69
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-39.03	24.22	37.48	-18.47	-1.23
Gross Profit, 1 Yr. Growth %	-57.71	27.48	51.58	-36.25	-58.91
EBITDA, 1 Yr. Growth %	-582.15	-38.34	-197.68	-55.19	-177.28
EBITA, 1 Yr. Growth %	-855.06	-36.4	-180.37	-62.55	-240.41
EBIT, 1 Yr. Growth %	-855.06	-36.4	-180.37	-62.55	-240.41
Earnings From Cont. Operations, 1 Yr. Growth %	322.84	-45.88	-155.68	-64.73	-325.24
Net Income, 1 Yr. Growth %	322.84	-45.88	-155.68	-64.73	-325.24
Normalized Net Income, 1 Yr. Growth %	310.1	-47.8	-159.5	-51.51	-235
Diluted EPS Before Extra, 1 Yr. Growth %	179.22	-50.72	-127.96	-57.71	-329.39
Accounts Receivable, 1 Yr. Growth %	72.1	33.24	14.96	-44.82	203.88
Inventory, 1 Yr. Growth %	37.24	-6.41	13.34	11.54	21.12
Net Property, Plant and Equip., 1 Yr. Growth %	-4.71	-2.84	12.88	-7.91	25.53
Total Assets, 1 Yr. Growth %	8.44	-24.27	51.35	-13.05	12.16
Tangible Book Value, 1 Yr. Growth %	-77.68	76.28	-415.5	28.72	11.62
Common Equity, 1 Yr. Growth %	-77.68	76.28	-415.5	28.72	11.62
Cash From Operations, 1 Yr. Growth %	-60.6	143.07	-94.73	-758.12	-238.26
Capital Expenditures, 1 Yr. Growth %	122.75	-56.96	82.96	11.58	27.77
Levered Free Cash Flow, 1 Yr. Growth %	82.31	-41.29	-76.07	-400.91	-324.44
Unlevered Free Cash Flow, 1 Yr. Growth %	107.54	-42.12	-98.64	-7.23K	-287.8
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-16.26	-12.97	30.68	5.87	-10.26
Gross Profit, 2 Yr. CAGR %	-29.12	-26.58	39.01	361.22	-48.82
EBITDA, 2 Yr. CAGR %	45.8	72.43	-22.39	-33.84	-41.15
EBITA, 2 Yr. CAGR %	38.18	119.14	-28.5	-45.14	-27.49
EBIT, 2 Yr. CAGR %	38.18	119.14	-28.5	-45.14	-27.49
Earnings From Cont. Operations, 2 Yr. CAGR %	22.85	51.27	-45.1	-55.68	-10.86
Net Income, 2 Yr. CAGR %	22.85	51.27	-45.1	-55.68	-10.86
Normalized Net Income, 2 Yr. CAGR %	20.98	48.56	-44.27	-46.28	-19.09
Diluted EPS Before Extra, 2 Yr. CAGR %	-28.77	17.31	-62.76	-65.61	-1.51
Accounts Receivable, 2 Yr. CAGR %	-14.42	51.43	23.76	-20.36	29.49
Inventory, 2 Yr. CAGR %	48.38	13.34	2.99	12.44	16.23
Net Property, Plant and Equip., 2 Yr. CAGR %	-4.81	-3.78	4.73	1.96	7.51
Total Assets, 2 Yr. CAGR %	27.39	-9.38	7.06	14.72	-1.24
Tangible Book Value, 2 Yr. CAGR %	-70.7	-37.27	135.83	101.52	19.86
Common Equity, 2 Yr. CAGR %	-70.7	-37.27	135.83	101.52	19.86
Cash From Operations, 2 Yr. CAGR %	-27.11	-2.14	-64.2	-41.1	201.65
Capital Expenditures, 2 Yr. CAGR %	52.54	-2.08	-11.26	42.88	19.4
Levered Free Cash Flow, 2 Yr. CAGR %	88.48	-1.58	-62.52	-15.15	159.88
Unlevered Free Cash Flow, 2 Yr. CAGR %	47.22	9.6	-91.12	-1.36	1.06K
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	3.85	-4.5	1.36	11.67	3.45
Gross Profit, 3 Yr. CAGR %	-4.09	-13.81	-6.51	-8.78	106
EBITDA, 3 Yr. CAGR %	3.13	9.44	42.67	-35.37	-30.32
EBITA, 3 Yr. CAGR %	1.95	6.69	56.86	-42.37	-24.96
EBIT, 3 Yr. CAGR %	1.95	6.69	56.86	-42.37	-24.96
Earnings From Cont. Operations, 3 Yr. CAGR %	1.4	-6.52	8.41	-52.63	-23.8
Net Income, 3 Yr. CAGR %	1.4	-6.52	8.41	-52.63	-23.8
Normalized Net Income, 3 Yr. CAGR %	0.33	-7.64	9.51	-46.8	-26.97
Diluted EPS Before Extra, 3 Yr. CAGR %	-29.69	-37	-27.11	-61.15	-35.27
Accounts Receivable, 3 Yr. CAGR %	-10.05	-0.82	38.14	-5.45	24.45
Inventory, 3 Yr. CAGR %	27.96	27.25	13.34	5.77	15.26
Net Property, Plant and Equip., 3 Yr. CAGR %	15.8	-4.16	1.48	0.33	9.28
Total Assets, 3 Yr. CAGR %	6.41	7.12	7.52	-0.11	13.86
Tangible Book Value, 3 Yr. CAGR %	-51.49	-46.71	7.48	92.73	65.5
Common Equity, 3 Yr. CAGR %	-51.49	-46.71	7.48	92.73	65.5
Cash From Operations, 3 Yr. CAGR %	9.93	8.9	-63.04	-5.52	-21.72
Capital Expenditures, 3 Yr. CAGR %	28.6	0.05	20.6	-4.22	37.65
Levered Free Cash Flow, 3 Yr. CAGR %	16.15	30.41	-38.58	-24.95	17.35
Unlevered Free Cash Flow, 3 Yr. CAGR %	23.61	7.85	-74.6	-17.42	22.25
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	33.05	17.71	13.85	-0.48	-3.46
Gross Profit, 5 Yr. CAGR %	93.98	36.83	11.26	-17.54	-33.31
EBITDA, 5 Yr. CAGR %	-9.11	-18.21	-7.96	-10.52	0.11
EBITA, 5 Yr. CAGR %	-9.21	-17.72	-11.54	-18.23	15.21
EBIT, 5 Yr. CAGR %	-9.21	-17.72	-11.54	-18.23	15.21
Earnings From Cont. Operations, 5 Yr. CAGR %	-1.12	-29.12	-20.67	-30.65	0.25
Net Income, 5 Yr. CAGR %	-1.24	-29.12	-20.67	-30.65	0.25
Normalized Net Income, 5 Yr. CAGR %	-9.16	-29.41	-20.21	-25.64	-2.98
Diluted EPS Before Extra, 5 Yr. CAGR %	-26.32	-45.43	-45.47	-50.49	-17.78
Accounts Receivable, 5 Yr. CAGR %	37.79	21.66	2.2	-9.15	34.61
Inventory, 5 Yr. CAGR %	27.9	16.49	17.32	21.1	14.49
Net Property, Plant and Equip., 5 Yr. CAGR %	2.66	4.66	11.24	-1.76	3.85
Total Assets, 5 Yr. CAGR %	-2.18	-5.03	6.67	10.09	3.92
Tangible Book Value, 5 Yr. CAGR %	-9.53	-18.43	-8.69	-9.28	12.27
Common Equity, 5 Yr. CAGR %	-9.53	-18.43	-8.69	-9.28	12.27
Cash From Operations, 5 Yr. CAGR %	-20.36	20.13	-29.82	-14.83	-14.41
Capital Expenditures, 5 Yr. CAGR %	11.44	-8.35	10.87	15.38	20.12
Levered Free Cash Flow, 5 Yr. CAGR %	-8.06	-20.26	-25.2	9.81	9.37
Unlevered Free Cash Flow, 5 Yr. CAGR %	-8.16	-19.64	-56.88	4.06	17.02